NDA 11521, held by Ivax Sub Teva Pharms. Rauwolfia Serpentina Root.
As of Nov 15, 2026, NDA 11521 (Rauwolfia Serpentina), held by Ivax Sub Teva Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Rauwolfia Serpentina50MG · tablet;oral | Rauwolfia Serpentina Root | Discontinued |
| Rauwolfia Serpentina100MG · tablet;oral | Rauwolfia Serpentina Root | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
